{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:33:11Z","timestamp":1772155991145,"version":"3.50.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/inf.0000000000001571","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T06:57:16Z","timestamp":1486709836000},"page":"513-515","source":"Crossref","is-referenced-by-count":35,"title":["Fever in Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases"],"prefix":"10.1097","volume":"36","author":[{"given":"Maren","family":"Paulmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-21-20210202","first-page":"625","article-title":"[Schwere arzneimittelinduzierte Hautreaktionen: Klinik, Diagnostik, \u00c4tiologie und Therapie] Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy.","volume":"13","author":"Paulmann","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"R3-21-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"R4-21-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R5-21-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R6-21-20210202","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990\u20131992). Structure and results of a population-based registry.","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R7-21-20210202","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/BCR.0b013e31827a2ac3","article-title":"Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.","volume":"34","author":"Hamilton","year":"2013","journal-title":"J Burn Care Res"},{"key":"R8-21-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/BCR.0000000000000208","article-title":"A 15-year review of pediatric toxic epidermal necrolysis.","volume":"36","author":"Quirke","year":"2015","journal-title":"J Burn Care Res"},{"key":"R9-21-20210202","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1542\/peds.2008-1923","article-title":"Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.","volume":"123","author":"Levi","year":"2009","journal-title":"Pediatrics"},{"key":"R10-21-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study.","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R11-21-20210202","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.","volume":"6","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"key":"R12-21-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R13-21-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/BCR.0000000000000204","article-title":"Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.","volume":"36","author":"Beck","year":"2015","journal-title":"J Burn Care Res"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:14:16Z","timestamp":1620940456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201705000-00021"}},"subtitle":["Laboratory Work-up and Antibiotic Therapy"],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001571","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727381476.793576482","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}